The U.S. Preventive Services Task Force recommends that physicians and patients take part in shared decision-making about both the benefits and the harms associated with lung cancer screening with low-dose CT (LDCT). According to a new study published in JAMA Internal Medicine, however, the quality of shared decision making in today’s healthcare environment is quite low.
The U.S. Preventive Services Task Force recommends that physicians and patients take part in shared decision-making about both the benefits and the harms associated with lung cancer screening with low-dose CT (LDCT). According to a new study published in JAMA Internal Medicine, however, the quality of shared decision making in today’s healthcare environment is quite low.